INKON Life Technology Co., Ltd. (SHE:300143)

China · Delayed Price · Currency is CNY

7.56

+0.13 (1.75%)

At close: Aug 4, 2026

-4.30% (1Y)

Market Cap	7.19B -5.9%
Revenue (ttm)	1.97B +27.1%
Net Income	64.31M -46.0%
EPS	0.06 -52.9%
Shares Out	967.06M
PE Ratio	114.56
Forward PE	n/a
Dividend	0.02 (0.26%)
Ex-Dividend Date	Jun 3, 2026

Volume	12,062,668
Open	7.46
Previous Close	7.43
Day's Range	7.46 - 7.61
52-Week Range	6.40 - 11.06
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 2,662

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300143

Full Company Profile

Financial Performance

In 2025, INKON Life Technology's revenue was 1.89 billion, an increase of 20.93% compared to the previous year's 1.56 billion. Earnings were 68.54 million, a decrease of -40.62%.

Financial Statements